An elderly man with rheumatoid arthritis and dyspnea

Chest

Volumn 135, Issue 4, 2009, Pages 1090-1093

  Nesheiwat, Joseph Paul ^a   Dillon, Karen ^a   McGlothan, Kim ^a   Zaman, Muhammad ^b   Carbone, Laura D ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; LEFLUNOMIDE; SPIRONOLACTONE; TERAZOSIN; ANTIRHEUMATIC AGENT; ISOXAZOLE DERIVATIVE;

AGED; ARTICLE; CASE REPORT; CYTOLOGY; DIFFUSE ALVEOLAR DAMAGAE; DIFFUSE ALVEOLAR DAMAGE; DYSPNEA; ECHOCARDIOGRAPHY; ELDERLY CARE; ELECTROCARDIOGRAM; HUMAN; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; LABORATORY TEST; LUNG LAVAGE; MALE; ORGANIZING PNEUMONIA; OXYGEN THERAPY; PRIORITY JOURNAL; RADIODIAGNOSIS; RESPIRATORY FAILURE; RHEUMATOID ARTHRITIS; TRANSBRONCHIAL BIOPSY; VITAL SIGN; CHEMICALLY INDUCED DISORDER; LUNG ALVEOLUS; PATHOLOGY; PNEUMONIA;

AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; ISOXAZOLES; MALE; PNEUMONIA; PULMONARY ALVEOLI;

EID: 64749087530     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-1501     Document Type: Article

References (10)

1. Berbescu EA, Katzenstein AL, Snow JL, et al. Transbronchial biopsy in usual interstitial pneumonia. Chest 2006; 129:1126-1131
2. Fuhrman C, Parrot A, Wislez M, et al. Spectrum of CD4 to CD8 T-cell ratios in lymphocytic alveolitis associated with methotrexate- induced pneumonitis. Am J Respir Crit Care Med 2001; 164:1186-1191
3. Kim DS. Interstitial lung disease in rheumatoid arthritis: recent advances. Curr Opin Pulm Med 2006; 12:346-353
4. Martin N, Innes JA, Lambert CM, et al. Hypersensitivity pneumonitis associated with leflunomide therapy. J Rheumatol 2007; 34:1934-1937
5. McEwen J, Purcell PM, Hill RL, et al. The incidence of pancytopenia in patients taking leflunomide alone or with methotrexate. Pharmacoepidemiol Drug Saf 2007; 16:65-73
6. Saag KG, Teng GG, Patkar NM, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008; 59:762-784
7. Van Riel PL, Smolen JS, Emery P, et al. Leflunomide: a manageable safety profile. J Rheumatol Suppl 2004; 71:21-24
8. Van Roon EN, Jansen TL, Houtman NM, et al. Leflunomide for the treatment of rheumatoid arthritis in clinical practice: incidence and severity of hepatotoxicity. Drug Saf 2004; 27:345-352
9. Welker L, Jorres RA, Costabel U, et al. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J 2004; 24:1000-1006
10. Winterbauer RH, Lammert J, Selland M, et al. Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis. Chest 1993; 104:352-361